Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Gaudium IVF
Price Band
₹75.0–79.0
Issue Size
₹165.0 Cr
Lot Size
189 shares
Min Investment
₹14,931
GMP
+₹0.0 (0.0%)
Issue Price
₹79.0
calendar_month Important Dates
bar_chart Subscription Status
Subscription data unavailable
trending_up Grey Market Premium (GMP)
GMP
₹0.0
GMP %
0.0%
Est. Listing
₹79.0
schedule Updated: 14 Jul 2026 15:52
Share GMP:
business About the Company
Gaudium IVF and Women Health Limited is an India-based fertility care provider specializing in In Vitro Fertilization (IVF) and related reproductive treatments. The company operates through a hub-and-spoke model and has expanded its presence across multiple states, with more than thirty centers comprising seven main hubs and twenty-eight spoke clinics. It has also formed strategic partnerships with infertility experts to increase awareness and access to Assisted Reproductive Technology (ART) and IVF services. Gaudium serves both domestic and international patients from countries such as Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman. Its key centers are located in major cities including Delhi (Janakpuri and Kailash Colony), Mumbai (Khar West), Ludhiana, Srinagar, Patna, and Bangalore. The company provides a wide range of fertility treatments, including IVF, ICSI, IUI, and ovulation induction, addressing infertility challenges in both men and women. It also offers gynecological care for conditions such as PCOS/PCOD and endometriosis, along with specialized management for high-risk pregnancies. Additionally, the centers provide advanced male infertility treatments, including specialized sperm retrieval procedures. Key strengths: A strong patient-focused care model An experienced and skilled medical team Advanced INTEGRA Ti laboratories for ICSI procedures Highly technical ultrasound-guided services Strategically located central hubs in major urban areas An asset-light operating structure
payments Company Financials (₹ Cr)
As of 2025-09-30
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 106.62 | 88.51 | 51.01 | 36.63 |
| Total Income | 49.75 | 70.96 | 48.15 | 44.26 |
| Profit After Tax | 12.51 | 19.13 | 10.32 | 13.53 |
| EBITDA | 18.95 | 28.63 | 19.27 | 20.07 |
| NET Worth | 58.85 | 46.30 | 26.99 | 22.73 |
| Reserves and Surplus | 28.16 | 15.60 | 26.00 | 21.74 |
| Total Borrowing | 22.51 | 18.93 | 15.73 | 9.78 |
Key Ratios
EPS
₹3.12
NAV
₹7.54
ROE
41.31%
ROCE
39.70%
RoNW
41.71%
P/B Value
10.48
P/E Ratio
25.36
Market Cap
₹575.02 Cr
PAT Margin
26.96%
Debt/Equity
0.41
Promoters
Manika Khanna, Peeyush Khanna and Vishad Khanna
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Funding capital expenditure towards establishment of New IVF Centers of the Company. 50.00 2 Repayment/pre-payment, in full or in part, of certain outstanding loans availed by the Company. 20.00 3 General Corporate Purposes 12.28 4 Issue Expenses 14.15 Total 96.43
info Issue Details
pie_chart Investor Allocation
Registrar
Lead Managers / Book Running
timeline IPO Timeline
Open
20 Feb 2026
Close
24 Feb 2026
Allotment
25 Feb 2026
Listing
27 Feb 2026